21st week of 2019 patent applcation highlights part 27 |
Patent application number | Title | Published |
20190152961 | PREPARATION OF SUFENTANIL CITRATE AND SUFENTANIL BASE | 2019-05-23 |
20190152962 | CYCLOPROPYL DERIVATIVES AS ROR-GAMMA MODULATORS | 2019-05-23 |
20190152963 | PYRAZOLE-OXAZOLIDINONE COMPOUND FOR ANTI-HEPATITIS B VIRUS | 2019-05-23 |
20190152964 | PI3K INHIBITOR, AND PHARMACEUTICALLY ACCEPTABLE SALT, POLYCRYSTALLINE FORM, AND APPLICATION THEREOF | 2019-05-23 |
20190152965 | AMINOPYRIDINE DERIVATIVES AS TAM FAMILY KINASE INHIBITORS | 2019-05-23 |
20190152966 | Methylamine Derivatives as Lysysl Oxidase Inhibitors for the Treatment of Cancer | 2019-05-23 |
20190152967 | PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA SELECTIVE AGONISTS FOR INHIBITION OF RETINAL PIGMENT EPITHELIUM DEGENERATION OR GEOGRAPHIC ATROPHY | 2019-05-23 |
20190152968 | AZEPIN-2-ONE DERIVATIVES AS RSV INHIBITORS | 2019-05-23 |
20190152969 | PYRIMIDINE OR PYRIDINE COMPOUNDS, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USES THEREOF | 2019-05-23 |
20190152970 | TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | 2019-05-23 |
20190152971 | Imidazo[1,2-A]Pyridine Derivatives, Methods for Preparing the Same and Use Thereof | 2019-05-23 |
20190152972 | MULTI-KINASE INHIBITOR COMPOUND, AND CRYSTAL FORM AND USE THEREOF | 2019-05-23 |
20190152973 | NOVEL HETEROCYCLIC DERIVATIVE COMPOUND AND USE THEREOF | 2019-05-23 |
20190152974 | SUBSTITUTED PTERIDINES USEFUL FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS | 2019-05-23 |
20190152975 | TERTIARY ALCOHOLS AS PI3K-y INHIBITORS | 2019-05-23 |
20190152976 | TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES AS LSD1 INHIBITORS | 2019-05-23 |
20190152977 | SUBSTITUTED HETEROARYL COMPOUNDS AND METHODS OF USE | 2019-05-23 |
20190152978 | CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF | 2019-05-23 |
20190152979 | SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALLOSTERIC MODULATORS OF GROUP II METABOTROPIC GLUTAMATE RECEPTORS | 2019-05-23 |
20190152980 | SUBSTITUTED 4-METHYL-PYRROLO[1,2-A]PYRIMIDINE-8-CARBOXAMIDE COMPOUNDS AND USES THEREOF FOR MODULATING GLUCOCEREBROSIDASE ACTIVITY | 2019-05-23 |
20190152981 | Compositions and Methods For Making Alkaloid Morphinans | 2019-05-23 |
20190152983 | SINGLE ENANTIOMER ANTIPARASITIC COMPOUNDS | 2019-05-23 |
20190152984 | OPTICALLY ACTIVE PYRANOCHROMENYL PHENOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 2019-05-23 |
20190152985 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | 2019-05-23 |
20190152986 | CRYSTAL FORM A OF MILBEMYCIN A3 OXIME AND PREPARATION METHOD THEREOF | 2019-05-23 |
20190152987 | IMIDAZOLES AS HISTONE DEMETHYLASE INHIBITORS | 2019-05-23 |
20190152988 | ISOINDOLINE, AZAISOINDOLINE, DIHYDROINDENONE AND DIHYDROAZAINDENONE INHIBITORS OF MNK1 AND MNK2 | 2019-05-23 |
20190152989 | NOVEL ULK1 INHIBITORS AND METHODS USING SAME | 2019-05-23 |
20190152990 | POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY | 2019-05-23 |
20190152991 | PRO-DRUGS OF NSAIAS WITH VERY HIGH SKIN AND MEMBRANES PENETRATION RATES AND THEIR NEW MEDICINAL USES | 2019-05-23 |
20190152992 | BENZODIOXANE DERIVATIVES AND THEIR PHARMACEUTICAL USE | 2019-05-23 |
20190152993 | Reversibly Switchable Surfactants and Methods of Use | 2019-05-23 |
20190152994 | POTASSIUM MIXTURES COMPOSITIONS AND METHODS | 2019-05-23 |
20190152995 | METHOD TO MAKE SCALABLE ULTRATHIN HEXAGONALLY FACETED METAL-ORGANIC FRAMEWORK (MOF) AND METHOD OF USING SAME FOR DETECTING EXPLOSIVES AND OTHER NITRO-AROMATIC COMPOUNDS | 2019-05-23 |
20190152996 | LANTHANUM COMPOUND AND METHODS OF FORMING THIN FILM AND INTEGRATED CIRCUIT DEVICE USING THE LANTHANUM COMPOUND | 2019-05-23 |
20190152997 | BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2019-05-23 |
20190152998 | SYNTHESIS OF m-TERPHENYL PENDANT BIS-ETHER LIGANDS AND METAL COMPLEX AND THEIR USE IN OLEFIN POLYMERIZATION | 2019-05-23 |
20190152999 | CATIONIC SILICON (II) COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF | 2019-05-23 |
20190153000 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CFTR | 2019-05-23 |
20190153001 | ORGANOTIN CLUSTERS, SOLUTIONS OF ORGANOTIN CLUSTERS, AND APPLICATION TO HIGH RESOLUTION PATTERNING | 2019-05-23 |
20190153002 | Novel Prodrugs And Methods Of Use Thereof | 2019-05-23 |
20190153003 | CHEMILUMINESCENCE ENHANCER AND CHEMILUMINESCENCE IMMUNODETECTION KIT | 2019-05-23 |
20190153004 | USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING OCULAR INFLAMMATORY DISEASES | 2019-05-23 |
20190153005 | MITOCHONDRIA-TARGETING FLUORESCENT POTASSIUM+ SENSOR AND METHOD OF MAKING THE SAME | 2019-05-23 |
20190153006 | PYRAZOLE COMPOUNDS AND METHODS FOR MAKING AND USING THE COMPOUNDS | 2019-05-23 |
20190153007 | Polydentate Binuclear Ring Metal Complexes and Devices Containing Same | 2019-05-23 |
20190153008 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | 2019-05-23 |
20190153009 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2019-05-23 |
20190153010 | ANTIBACTERIAL SIDEROMYCINS | 2019-05-23 |
20190153011 | RENEWABLE AROMATICS FROM LIGNOCELLULOSIC LIGNIN | 2019-05-23 |
20190153012 | ENHANCED COUPLING OF STEREODEFINED OXAZAPHOSPHOLIDINE PHOSPHORAMIDITE MONOMERS TO NUCLEOSIDE OR OLIGONUCLEOTIDE | 2019-05-23 |
20190153013 | METHOD FOR EXTRACTING ACTIVE INGREDIENTS | 2019-05-23 |
20190153014 | UTILITY OF NEMATODE SMALL MOLECULES | 2019-05-23 |
20190153015 | STABLE HYDROLYSIS-RESISTANT SYNTHETIC POLYRIBOSYLRIBITOLPHOSPHATE DERIVATIVES AS VACCINES AGAINST HAEMOPHILUS INFLUENZAE TYPE B | 2019-05-23 |
20190153016 | NOVEL TETRAGALNAC AND PEPTIDE CONTAINING CONJUGATES AND METHODS FOR DELIVERY OF OLIGONUCLEOTIDES | 2019-05-23 |
20190153017 | BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-4'-FLUORO-N6-SUBSTIT- UTED-6-AMINO-2-SUBSTITUTED PURINE NUCLEOTIDES FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTION | 2019-05-23 |
20190153018 | NOVEL CYTOTOXIC AGENTS THAT PREFERENTIALLY TARGET LEUKEMIA INHIBITORY FACTOR (LIF) FOR THE TREATMENT OF MALIGNANCIES AND AS NEW CONTRACEPTIVE AGENTS | 2019-05-23 |
20190153019 | FUNCTIONALIZED BILE ACIDS FOR THERAPEUTIC AND MATERIAL APPLICATIONS | 2019-05-23 |
20190153020 | Preparation and Uses of Obeticholic Acid | 2019-05-23 |
20190153021 | THERAPEUTIC COMPOUNDS | 2019-05-23 |
20190153022 | C4-MODIFIED OLEANOLIC ACID DERIVATIVES FOR INHIBITION OF IL-17 AND OTHER USES | 2019-05-23 |
20190153023 | Steroid 6.7.Beta.-Epoxides as Chemical Intermediates | 2019-05-23 |
20190153024 | NOVEL SALTS AND POLYMORPHS OF SCY-078 | 2019-05-23 |
20190153025 | Dithioamine Reducing Agents | 2019-05-23 |
20190153026 | IMPROVED METHOD FOR DECONTAMINATING A BIOLOGICAL MATERIAL BY PARTITIONING AND INACTIVATION | 2019-05-23 |
20190153027 | Methods For Increasing The Capacity Of Purification Processes | 2019-05-23 |
20190153028 | METHOD FOR PROTEIN PURIFICATION | 2019-05-23 |
20190153029 | ANTI-INFLAMMATORY TRIPEPTIDES | 2019-05-23 |
20190153030 | PEPTIDE, COMPOSITION COMPRISING SAID PEPTIDE AND USES THEREOF, IN PARTICULAR COSMETIC USES | 2019-05-23 |
20190153031 | NOVEL MOLECULES FOR THE TREATMENT OF INFLAMMATION | 2019-05-23 |
20190153032 | CHIRAL PEPTIDES | 2019-05-23 |
20190153033 | NOVEL PEPTIDE | 2019-05-23 |
20190153034 | VIRAL VECTOR FOR THE TARGETED TRANSFER OF GENES IN THE BRAIN AND SPINAL CORD | 2019-05-23 |
20190153035 | PEPTIDE INHIBITORS OF CALCIUM OXALATE MONOHYDRATE CRYSTALLIZATION AND USES THEREOF | 2019-05-23 |
20190153036 | VANCOMYCIN DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2019-05-23 |
20190153037 | NON-FRET CELL BASED ASSAY | 2019-05-23 |
20190153038 | METHOD FOR SIGNIFICANTLY INCREASING LENTIVIRAL PRODUCTION | 2019-05-23 |
20190153039 | VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER | 2019-05-23 |
20190153040 | Filovirus Consensus Antigens, Nucleic Acid Constructs and Vaccines Made Therefrom, and Methods of Using Same | 2019-05-23 |
20190153041 | VIRUS-LIKE PARTICLES AND METHODS OF USE | 2019-05-23 |
20190153042 | ANTIMICROBIAL PEPTIDES DERIVED FROM HEPATITIS B VIRUS CORE PROTEIN ARGININE-RICH DOMAIN | 2019-05-23 |
20190153043 | RECOMBINANT VIRAL VECTORS | 2019-05-23 |
20190153044 | MHC Class I Epitope Delivering Polypeptides | 2019-05-23 |
20190153045 | PLANT-DERIVED ELASTIN BINDING PROTEIN LIGANDS AND METHODS OF USING THE SAME | 2019-05-23 |
20190153046 | CHITIN, HYDROLYSATE AND PRODUCTION OF AT LEAST ONE DESIRED PRODUCT FROM INSECTS BY MEANS OF ENZYMATIC HYDROLYSIS, COMPRISING A COMBINATION OF STEPS PERFORMED PRIOR TO THE ENZYMATIC HYDROLYSIS | 2019-05-23 |
20190153047 | TRANSGENIC SILKWORMS CAPABLE OF PRODUCING CHIMERIC SPIDER SILK POLYPEPTIDES AND FIBERS | 2019-05-23 |
20190153048 | SYSTEM AND METHOD FOR THE PRODUCTION OF A BIOLOGICAL MESH | 2019-05-23 |
20190153049 | ANTI-PLACENTA-CHONDROITIN-SULFATE CHIMERIC ANTIGEN RECEPTOR AND APPLICATION THEREOF | 2019-05-23 |
20190153050 | DUAL-AAV VECTOR-BASED SYSTEMS AND METHODS FOR DELIVERING OVERSIZED GENES TO MAMMALIAN CELLS | 2019-05-23 |
20190153051 | FUSION PROTEIN OF C2 DOMAIN AND AKT KINASE DOMAIN FRAGMENT AND USE THEREOF | 2019-05-23 |
20190153052 | TREATMENT WITH A PHARMACEUTICAL COMPOSITION COMPRISING MANF2 NUCLEIC ACID | 2019-05-23 |
20190153053 | PEPTIDES OF BROMODOMAIN TESTIS-SPECIFIC PROTEIN (BRDT) | 2019-05-23 |
20190153054 | BMP PEPTIDES & METHODS OF USE | 2019-05-23 |
20190153055 | FUSION PROTEIN COMPRISING CCL3 VARIANT AND USE THEREOF | 2019-05-23 |
20190153056 | Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases | 2019-05-23 |
20190153057 | MULTI-LEVEL SPECIFIC TARGETING OF CANCER CELLS | 2019-05-23 |
20190153058 | MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES | 2019-05-23 |
20190153059 | PEPTIDE ANALOGS | 2019-05-23 |
20190153060 | LONG-ACTING CONJUGATE OF TRIPLE GLUCAGON/GLP-1/GIP RECEPTOR AGONIST | 2019-05-23 |
20190153061 | TREATMENT OF CANCER USING 5 HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR | 2019-05-23 |